IBD Evidence

Sintomi

Li ngħixu ma' IBD: tħossok imħasseb, u l-parti li ħadd ma jkejjel

L-immunità fuq il-karta u l-immunità kif esperjenzata huma affarijiet differenti, u l-vojt huwa fejn jgħix ħafna mill-piż.

Aġġornat 2 min read 22 ċitazzjonijiet Saħħa tal-evidenza 3/5

Tħossok imħasseb

Tħossok imħasseb huwa fost is-sintomi l-aktar rapportati fl-IBD u fost l-aktar li ma jittrattawx. Jibqa' f'frazzjoni kbira tan-nies li l-infjammazzjoni tagħhom hija kkontrollata, li jfisser li mhuwiex sempliċement markatur ta' attivitá tal-marda.

Il-kontribwenti jinkludu l-anemija (nuqqas ta' ferra huwa komuni ħafna u korrettabbli), disturb fil-ħin tal-ħolqien, effetti tal-mediċini, infjammazzjoni kronika, u l-piż psikoloġiku ta' marda imprevedibbli. Il-korrettabbli huma ta' valur biex jiġu segwiti b'mod esplicitu, għax ħadd ma se jsemmihom għalik f'appuntament ta' ħmistax-il minuta li jiffoka fuq il-calprotectin.

Il-piż tat-tħossok imħasseb fl-IBD

Saħħa mentali

Ir-rati ta' ansjetà u depressjoni fl-IBD jespandu b'mod sostanzjali r-rati ta' sfond. L-evidenza ovvia — li ngħixu ma' marda imprevedibbli, stigmata, li xi drabi tikkawża inkontinenza hija tħassib — hija vera u probabbilment mhix l-istorja kollha, meta wieħed iqis il-passi infjammatorji u l-passi tal-ġilda u tal-moħħ koperti fuq is-sit tagħna gut-brain evidence site.

Dak li huwa prattikament importanti huwa li dan huwa trattabbli u spiss jintilef. L-appoġġ psikoloġiku huwa parti mill-kura tal-IBD fil-gwida Ewropea u huwa distribwit b'mod mhux uniformi.

Il-piż prattiku

  • Ansjetà dwar l-aċċess għall- toilet, li tikkonfina t-travel, ix-xogħol u l-ħajja soċjali aktar milli japprezzaw il-kliniċi tipikament.
  • Imprevedibbiltà. Il-pjanar huwa diffiċli meta flare jista' jasal mingħajr twissija.
  • Ħarsien tad-dieta. Triggers individwali, l-ebda lista valida, u ħafna pariri kontradittorji — ara diet.
  • Impjieg. Tħossok imħasseb u urġenza jinteraġixxu ħażin ma' mudelli ta' xogħol rigidi.
  • Travel. Ħażna tal-mediċini, sigurtà tal-ikel u aċċess — koperti fuq is-sit tagħna travel health site.

Epidemioloġija

L-inċidenza tal-IBD hija għolja u stabbli fl-Ewropa u fl-Nord America u qed tiżdied b'mod qawwi f'pajjiżi ġodda industrijalizzati. Dak il-patruna ġeografiku huwa wieħed mill-aktar argumenti b'saħħithom għal komponent ambjentali — dieta, igiene, antibiotiks u l-mikrobioma huma kollha kandidati, u l-ebda wieħed mhu stabbilit.

Mistoqsijiet komuni

Għaliex jien eżawst jekk jien fl-immunità?
Tħossok imħasseb spiss jibqa' wara l-kontroll infjammatorju. Iċċekkja ferritin u B12 l-ewwel; huma komuni, korrettabbli u spiss jintilef.
Qed tagħmel stress il-flare tiegħi?
Stress plausibbilment jaffettwa s-sintomi u l-evidenza li jikkawża infjammazzjoni hija iktar dgħajfa mill-mudell folkloristiku. Mhux kulħadd huwa ħtija tiegħek.
Se jkolli bżonn operazzjoni?
Minorità sostanzjali għandhom, u l-proporzjon naqas hekk kif it-terapija effettiva waslet aktar kmieni — ara treatment.
Nista' nivvjaġġa?
Iva, bil-pjanar madwar il-mediċini, l-assigurazzjoni u s-sigurtà tal-ikel.

Referenzi

Kull ċitazzjoni hawn taħt tgħaqqad mal-record oriġinali peer-reviewed fuq PubMed jew permezz ta' DOI. Xejn hawnhekk m'għandux ikun sostitut għal parir mediku.

  1. Management of paediatric ulcerative colitis, part 2: Acute severe colitis-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organization Assa A, Aloi M, Van Biervliet S, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40528309
  2. Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation Wine E, Aloi M, Van Biervliet S, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40677018Full text
  3. Risk factors for herpes zoster infections: a systematic review and meta-analysis unveiling common trends and heterogeneity patterns Steinmann M, Lampe D, Grosser J, et al. · Infection · 2024 · Meta-analysis DOIPubMed 38236326Full text
  4. Acute severe ulcerative colitis trials: the past, the present and the future Honap S, Jairath V, Sands BE, et al. · Gut · 2024 · Systematic review DOIPubMed 38834296Full text
  5. Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses Buie MJ, Quan J, Windsor JW, et al. · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023 · Meta-analysis DOIPubMed 35863682
  6. Nutrition, Nutritional Status, Micronutrients Deficiency, and Disease Course of Inflammatory Bowel Disease Valvano M, Capannolo A, Cesaro N, et al. · Nutrients · 2023 · Systematic review DOIPubMed 37686856Full text
  7. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review Kuenzig ME, Fung SG, Marderfeld L, et al. · Gastroenterology · 2022 · Systematic review DOIPubMed 34995526
  8. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis Barberio B, Zamani M, Black CJ, et al. · The lancet. Gastroenterology & hepatology · 2021 · Meta-analysis DOIPubMed 33721557
  9. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD Turner D, Ricciuto A, Lewis A, et al. · Gastroenterology · 2021 · Systematic review DOIPubMed 33359090
  10. ACG Clinical Guideline: Management of Irritable Bowel Syndrome Lacy BE, Pimentel M, Brenner DM, et al. · The American journal of gastroenterology · 2021 · Clinical guideline DOIPubMed 33315591
  11. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies Ng SC, Shi HY, Hamidi N, et al. · Lancet (London, England) · 2017 · Systematic review DOIPubMed 29050646
  12. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target Peyrin-Biroulet L, Sandborn W, Sands BE, et al. · The American journal of gastroenterology · 2015 · Systematic review DOIPubMed 26303131
  13. Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study Ferrante M, D'Haens G, Jairath V, et al. · Lancet (London, England) · 2024 · Randomised controlled trial DOIPubMed 39581202
  14. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial Cox SR, Lindsay JO, Fromentin S, et al. · Gastroenterology · 2020 · Randomised controlled trial DOIPubMed 31586453
  15. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis Sands BE, Peyrin-Biroulet L, Loftus EV Jr, et al. · The New England journal of medicine · 2019 · Randomised controlled trial DOIPubMed 31553834
  16. Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies Caron B, Honap S, Peyrin-Biroulet L · Journal of Crohn's & colitis · 2024 · Review DOIPubMed 39475082Full text
  17. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life Nguyen TV, Damiani G, Orenstein LAV, et al. · Journal of the European Academy of Dermatology and Venereology : JEADV · 2021 · Review DOIPubMed 32460374
  18. Iron Deficiency Anemia in Inflammatory Bowel Diseases-A Narrative Review Mahadea D, Adamczewska E, Ratajczak AE, et al. · Nutrients · 2021 · Review DOIPubMed 34836263Full text
  19. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities Elmets CA, Leonardi CL, Davis DMR, et al. · Journal of the American Academy of Dermatology · 2019 · Review DOIPubMed 30772097
  20. Fatigue in inflammatory bowel disease Grimstad T, Norheim KB · Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke · 2016 · Review DOIPubMed 27830906
  21. Global evolution of inflammatory bowel disease across epidemiologic stages Hracs L, Windsor JW, Gorospe J, et al. · Nature · 2025 · Journal article DOIPubMed 40307548Full text
  22. Psychological symptoms and quality of life in patients with inflammatory bowel disease in China: A multicenter study Zhang J, Liu C, An P, et al. · United European gastroenterology journal · 2024 · Journal article DOIPubMed 38315582Full text

Din il-paġna ġiet tradotta awtomatikament mill-Ingliż. Il-citazzjonijiet u n-numri mhumiex mibdula. Aqra l-original Ingliż jekk xi ħaġa taqra b'mod stramb. Aqra l-original Ingliż